NDC 33342-447 – Pyrazinamide
Pyrazinamide 500 mg/1 · Tablet · Oral
Product NDC33342-447
Product details
- Brand name
- Pyrazinamide
- Generic name
- Pyrazinamide
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA212541
- Marketed since
- July 27, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Antimycobacterial
Active ingredients
- Pyrazinamide 500 mg/1
Package NDC codes (7)
| Package NDC | Description | Since |
|---|---|---|
| 33342-447-03 | 10 TABLET in 1 BOTTLE (33342-447-03) | Jul 27, 2020 |
| 33342-447-07 | 30 TABLET in 1 BOTTLE (33342-447-07) | Jul 27, 2020 |
| 33342-447-09 | 60 TABLET in 1 BOTTLE (33342-447-09) | Jul 27, 2020 |
| 33342-447-10 | 90 TABLET in 1 BOTTLE (33342-447-10) | Jul 27, 2020 |
| 33342-447-11 | 100 TABLET in 1 BOTTLE (33342-447-11) | Jul 27, 2020 |
| 33342-447-12 | 10 TABLET in 1 BLISTER PACK (33342-447-12) | Jul 27, 2020 |
| 33342-447-15 | 500 TABLET in 1 BOTTLE (33342-447-15) | Jul 27, 2020 |